LT, L., HA, L., & SF, L. (2026). Real-World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease. Annals of clinical and translational neurology, 13(4), 665. https://doi.org/10.1002/acn3.70246
Chicago Style (17th ed.) CitationLT, Lin, Lin HA, and Lin SF. "Real-World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease." Annals of Clinical and Translational Neurology 13, no. 4 (2026): 665. https://doi.org/10.1002/acn3.70246.
MLA (9th ed.) CitationLT, Lin, et al. "Real-World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease." Annals of Clinical and Translational Neurology, vol. 13, no. 4, 2026, p. 665, https://doi.org/10.1002/acn3.70246.
Warning: These citations may not always be 100% accurate.